chr11-55796364-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001004735.1(OR5D14):āc.809G>Cā(p.Arg270Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000088 in 1,613,766 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004735.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5D14 | NM_001004735.1 | c.809G>C | p.Arg270Pro | missense_variant | 1/1 | ENST00000335605.1 | NP_001004735.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5D14 | ENST00000335605.1 | c.809G>C | p.Arg270Pro | missense_variant | 1/1 | 6 | NM_001004735.1 | ENSP00000334456.1 |
Frequencies
GnomAD3 genomes AF: 0.000428 AC: 65AN: 151928Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251288Hom.: 1 AF XY: 0.0000736 AC XY: 10AN XY: 135824
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1461720Hom.: 2 Cov.: 35 AF XY: 0.0000371 AC XY: 27AN XY: 727174
GnomAD4 genome AF: 0.000428 AC: 65AN: 152046Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 28AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2022 | The c.809G>C (p.R270P) alteration is located in exon 1 (coding exon 1) of the OR5D14 gene. This alteration results from a G to C substitution at nucleotide position 809, causing the arginine (R) at amino acid position 270 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at